AU Patent

AU2012211421B2 — Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications

Assigned to University of North Carolina at Chapel Hill · Expires 2014-06-12 · 12y expired

What this patent protects

Abstract The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications. w 0ui

USPTO Abstract

Abstract The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications. w 0ui

Drugs covered by this patent

berdazimer-sodium (BERDAZIMER SODIUM)

Patent Metadata

Patent number: AU2012211421B2
Jurisdiction: AU
Classification: —
Expires: 2014-06-12
Drug substance claim: No
Drug product claim: No
Assignee: University of North Carolina at Chapel Hill
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.